Vanguard Group’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.6M | Buy |
|
|||||
|
2025
Q1 | $12.1M | Buy |
|
|||||
|
2024
Q4 | $13M | Buy |
|
|||||
|
2024
Q3 | $5.26M | Buy |
|
|||||
|
2024
Q2 | $4.14M | Hold |
|
|||||
|
2024
Q1 | $5.17M | Buy |
|
|||||
|
2023
Q4 | $3.34M | Buy |
|
|||||
|
2023
Q3 | $3.61M | Sell |
|
|||||
|
2023
Q2 | $4.97M | Buy |
|
|||||
|
2023
Q1 | $4.4M | Buy |
|
|||||
|
2022
Q4 | $2.5M | Buy |
|
|||||
|
2022
Q3 | $3.42M | Hold |
|
|||||
|
2022
Q2 | $3.23M | Hold |
|
|||||
|
2022
Q1 | $6.1M | Buy |
|
|||||
|
2021
Q4 | $8.31M | Buy |
|
|||||
|
2021
Q3 | $8.23M | Buy |
|
|||||
|
2021
Q2 | $2.9M | Buy |
|
|||||
|
2021
Q1 | $1.31M | Buy |
|
|||||
|
2020
Q4 | $971K | Buy |
|
|||||
|
2020
Q3 | $755K | Buy |
|
|||||
|
2020
Q2 | $985K | Hold |
|
|||||
|
2020
Q1 | $621K | Buy |
|
|||||
|
2019
Q4 | $690K | Sell |
|
|||||
|
2019
Q3 | $583K | Buy |
|
|||||
|
2019
Q2 | $652K | Buy |
|
|||||
|
2019
Q1 | $960K | Buy |
|
|||||
|
2018
Q4 | $163K | Sell |
|
|||||
|
2018
Q3 | $551K | Buy |
|
|||||
|
2018
Q2 | $610K | Buy |
|
|||||
|
2018
Q1 | $1.77M | Buy |
|
|||||
|
2017
Q4 | $1.71M | Buy |
|
|||||
|
2017
Q3 | $2.17M | Sell |
|
|||||
|
2017
Q2 | $1.5M | Buy |
|
|||||
|
2017
Q1 | $1.52M | Buy |
|
|||||
|
2016
Q4 | $767K | Sell |
|
|||||
|
2016
Q3 | $1.48M | Buy |
|
|||||
|
2016
Q2 | $1.22M | Buy |
|
|||||
|
2016
Q1 | $787K | Buy |
|
|||||
|
2015
Q4 | $1.7M | Buy |
|
|||||
|
2015
Q3 | $1.56M | Sell |
|
|||||
|
2015
Q2 | $2.89M | Buy |
|